The failure of a candidate drug can cost millions – so many chemists are turning to software that provides modelling capabilities and multi-parameter optimisation
Robert Roe looks back over the year at technology and processes driving trends in the laboratory
The Edge is a leading supplier of innovative software and services to the pharmaceutical and biotechnology industry. We specialise in helping research organisations to capture and manage their data more effectively shortening project time lines and reducing the manual work associated with biological studies.
Our premier software platform ('BioRails') provides a collaborative environment designed to capture and manage high quality data whilst protecting IP. This provides an effective electronic laboratory notebook for biological research.
In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.
At the end of February physIQ and the US Department of Veteran’s Affairs published data from a clinical trial demonstrating the use of physIQ’s machine-learning algorithm to predict when an individual patient with previously diagnosed heart failure will likely require a readmission to hospital.
Cloud research tools provide a platform for new avenues of scientific research by providing fast access to bare-metal resources.
New processors and GPU technology continue to demand more power than the previous generations, combining this with increasingly dense architectures requires cooling solutions such as liquid or immersion cooling.
Tate Cantrell, CTO, Verne Global, comments on the cost of the AI computing revolution
European researchers are working on a new programming environment for exascale computing that aims to make using these systems more efficient and programmers more productive.
